Glyconics, is an early stage medical diagnostics business launching a low-cost easy to use hand held device, initially targeting the Chronic Obstructive Pulmonary Disease (COPD) market – the third largest cause of death worldwide (£14bn) and Diabetes (£16bn) – seventh largest cause of death worldwide.

Health providers globally are demanding improved Point of Care (PoC) diagnostics because current approaches are expensive, slow, complex and often invasive.

Our technology platform is based on Infrared Spectroscopy (IR). This is the first time IR spectroscopy has been miniaturised to work at low cost in-home and in-clinic. Our device will give accurate results in just minutes for use by healthcare professionals and diagnosed patients.

With a low-cost disposable cartridge, the Glyconics approach is non-invasive and allows the testing of raw samples (eg sputum, saliva, urine, etc). This allows the device to be used by non-experts for diagnostics and in-home for disease monitoring.

Venturefest Oxford

The 2019 event will be on  Wednesday 11th September at Oxford Brookes University. 

Find out more >



Innovation Showcase

The showcase welcomed the most innovative and exciting business innovations. 

Find out more >

Pitching for Success

Venturefest's elevator pitch competition. Sponsored by Penningtons Manches.

Find out more >

Get Connected

Get connected with key business support services from across Oxfordshire.

Find out more >

Our Partners